Latest Capital Raise News

Aerometrex Limited has reported a robust half-year performance with record revenue growth and a dramatic increase in EBITDA, signalling strong operational momentum as it advances its SaaS transition.

BPH Global reports a modest sales dip in its ninth month due to seasonal rains and Chinese New Year effects but strengthens its Indonesian seaweed operations with a fresh A$1 million capital injection.

WAM Active Limited has successfully closed an oversubscribed entitlement offer, raising $70.7 million and increasing its asset base by over 84%, enhancing liquidity and market presence.

Tartana Minerals is advancing its strategic metals portfolio in Far North Queensland with a robust 2026 drilling program and ongoing copper sulphate production, aiming to unlock significant resource potential across silver, gold, and copper assets.

Celsius Resources has raised A$9.3 million through a well-supported institutional placement, strengthening its balance sheet to advance the financing and early development of its flagship MCB copper-gold project in the Philippines.

JCurve Solutions has reported a strong half-year performance, returning to profitability with a 32% increase in revenue to $7.02 million, driven by higher NetSuite commissions and a strategic shift towards larger customers.

VEEM Limited reports half-year revenue close to guidance with improved cash flow, offset by a significant $24.8 million non-cash impairment tied to its gyro product upgrade. The transition to the new Mark III gyro design has temporarily stalled sales as customers await delivery.

Barton Gold Holdings has distributed over $640,000 in Junior Minerals Exploration Incentive tax credits to investors from its June 2025 placement, enhancing returns amid strong exploration activity.

Aurora Labs reported a 15% revenue decline and a 12% increase in net loss for H1 2026, yet marked a strategic breakthrough with its first defence propulsion order and a successful $5.5 million capital raise.

FortifAI Limited has raised $5 million through a strategic placement led by a major Australian institutional fund manager, reinforcing its balance sheet and accelerating its AI development and commercialisation plans.

Contact Energy has issued over 51 million new shares at NZD 8.75 each, representing a 5.17% increase in its ordinary shares, aiming to strengthen its shareholder base through a carefully structured placement.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.